CDs

• CD203
  1 June 2009

  References
  CD203c is overexpressed on neoplastic mast cells in systemic mastocytosis and is upregulated upon IgE receptor cross-linking. Hauswirth AW, Escribano L, Prados A, Nuñez R, Mirkina I, Kneidinger M, Florian S, Sonneck K, Vales A, Schernthaner GH, Sanchez-Muñoz L, Sperr WR, Bühring HJ, Orfao A, Valent P. Int J Immunopathol Pharmacol. 2008 Oct-Dec;21(4):797-806. PMID: (...)

• Cd25
  1 June 2009

  References
  Hahn HP, Hornick JL. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis. Am J Surg Pathol. 2007 Nov;31(11):1669-76. PMID: #18059223#

• CD207
  9 October 2008

  langerin, CLEC4K

• CD38
  14 May 2008

  WP
  Definition: CD38 is an ectoenzyme involved in transmembrane signaling and cell adhesion and is used as a disease marker for leukemias and myeloma.
  Pathology
  CLL / chronic lymphocytic leukemia CD38 is a dependable negative prognostic marker for chronic lymphocytic leukemia (CLL). CD38 is a component of a complex network delivering growth and survival signals to CLL cells. In conjunction with chemokines and their receptors, CD38 also influences cell migratory responses.
  Targeted (...)

• CD107a
  18 February 2008

  lysosome-associated membrane protein 1 (LAMP-1)

• CD107s
  18 February 2008

  CD107a CD107b
  See also
  CDs

• CD30
  5 February 2008

  Ki-1, TNFRSF8

• CD40
  30 January 2008

  Definition: CD40 is a cell surface receptor that is expressed on the surface of all mature B cells, most mature B-cell malignancies, and some early B-cell acute lymphocytic leukemias, but is not expressed on plasma cells. It is also expressed on monocytes, dendritic cells, endothelial cells, and epithelial cells.
  Pathology
  Mutations in CD40 or CD40 ligand (CD40L) are known to cause hyper-IgM syndrome, in which T-cell and B-cell interaction is disrupted, thus preventing isotype switching (...)

• CD56
  15 January 2008

  NCAM-1, NCAM1

• CD7
  15 January 2008

  T-cell antigen 7

0 | 10 | 20 | 30 | 40